BMEDvsFXHETF Comparison
VS
iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. First Trust Health Care AlphaDEX Fund ETF (FXH) is part of the US Health Care segment. BMED's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, FXH's top sector exposures are Healthcare. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.61% for FXH. BMED is up 14.51% year-to-date (YTD) with +$5M in YTD flows. FXH performs better with 17.21% YTD performance, and +$33M in YTD flows. Run a side-by-side ETF comparison of BMED and FXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BMED vs FXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/16/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED FXH | +3.05%+1.46% | +12.16%+7.13% | +14.51%+17.21% | +24.44%+20.21% | +54.98%+39.96% | +20.00%+16.03% |
| Flows | BMED FXH | --$32M | +$1M+$33M | +$5M+$33M | +$6M+$39M | +$7M-$482M | +$6M-$458M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED FXH | +21.82%+15.06% | +17.81%+15.52% | +16.86%+15.68% | +18.13%+16.93% |
| Max drawdown | BMED FXH | -5.85%-4.82% | -14.71%-12.07% | -19.76%-17.66% | -32.14%-27.47% |
| Max drawdown duration | BMED FXH | 31d52d | 196d168d | 237d395d | 1479d1638d |
Trading data
BMED | FXH | |
Last sale 10/16/2026 at 6:23 PM | $34.55 | $132.45 |
| Previous close 10/16/2026 | $35.06 | $132.43 |
| Consolidated volume 10/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BMED
is actively managed and doesn’t replicate an indexBMED | FXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/16/2026 at 6:23 PM
Live
Closed
BMED | FXH | |
|---|---|---|
| Last price | $34.55 | $132.45 |
| 1D performance | -1.45% | +0.01% |
| AuM | $13.83 M | $1.12 B |
| E/R | 0.77% | 0.61% |
Characteristics
BMED | FXH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | iShares | First Trust |
| Benchmark | - | StrataQuant Health Care Index |
| N° of holdings | 53 | 72 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 29, 2020 | May 8, 2007 |
| ESG | No | No |
Advertisement
Exposure
Countries
BMED
USA
87.23%
Other
12.77%
FXH
USA
93.13%
Other
6.87%
Sectors
BMED
Healthcare
98.95%
Other
1.05%
FXH
Healthcare
98.23%
Other
1.77%
Advertisement
Diversification
BMED
Total weight of top 15 holdings out of 15
58.7%
FXH
Total weight of top 15 holdings out of 15
35.47%
Top 15 holdings
Data as of August 31, 2026
BMED
Gilead Sciences, Inc.
5.01%
Merck & Co., Inc.
4.99%
AbbVie, Inc.
4.61%
Johnson & Johnson
4.27%
Charles River Laboratories International, Inc.
4.22%
Thermo Fisher Scientific, Inc.
4.12%
Edwards Lifesciences Corp.
3.95%
Moderna, Inc.
3.86%
IQVIA Holdings, Inc.
3.72%
Danaher Corp.
3.64%
Vertex Pharmaceuticals, Inc.
3.56%
Waters Corp.
3.53%
Biogen, Inc.
3.45%
Mettler-Toledo International, Inc.
3.16%
DexCom, Inc.
2.61%
FXH
Regeneron Pharmaceuticals, Inc.
2.86%
Pfizer Inc.
2.56%
Natera, Inc.
2.55%
Solventum Corp.
2.55%
Zimmer Biomet Holdings, Inc.
2.49%
Universal Health Services, Inc.
2.48%
Boston Scientific Corp.
2.43%
Guardant Health, Inc.
2.37%
Tenet Healthcare Corp.
2.29%
Halozyme Therapeutics, Inc.
2.22%
The Cigna Group
2.22%
Globus Medical, Inc.
2.20%
Centene Corp.
2.20%
Corcept Therapeutics, Inc.
2.10%
Encompass Health Corp.
1.95%
Frequently asked questions about BMED and FXH
How have the BMED and FXH ETFs performed in 2026?
As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while FXH has returned 17.21%. That puts FXH better performer ahead so far this year.
Which ETF is attracting more investor money: BMED or FXH?
Year-to-date, the BMED ETF saw +$5M in flows, compared to +$33M for FXH.
Which ETF is more volatile: BMED or FXH?
Over the past year, BMED had a volatility of 17.81%, while FXH experienced 15.52%.
Which ETF is bigger: BMED or FXH?
As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while FXH manages $1.12 B.
What sectors do the BMED and FXH ETFs invest in?
BMED leans toward sectors like Healthcare. Meanwhile, FXH focuses on Healthcare.
What are the top holdings of the BMED ETF and FXH ETF?
BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. FXH holds in its top three: Regeneron Pharmaceuticals, Inc., Pfizer Inc. and Natera, Inc..
Which ETF is more diversified: BMED or FXH?
BMED holds 55 securities with 58.7% of its assets in the top 15. FXH has 72 securities and a top 15 weight of 35.47%.
Advertisement
Advertisement
